These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16773483)

  • 1. Usefulness of procalcitonin to differentiate typical from atypical community-acquired pneumonia.
    Jereb M; Kotar T
    Wien Klin Wochenschr; 2006 Apr; 118(5-6):170-4. PubMed ID: 16773483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
    Nascimento-Carvalho CM; Cardoso MR; Barral A; Araújo-Neto CA; Guerin S; Saukkoriipi A; Paldanius M; Vainionpää R; Lebon P; Leinonen M; Ruuskanen O; Gendrel D
    Scand J Infect Dis; 2010 Sep; 42(9):644-9. PubMed ID: 20438288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.
    Christ-Crain M; Stolz D; Bingisser R; Müller C; Miedinger D; Huber PR; Zimmerli W; Harbarth S; Tamm M; Müller B
    Am J Respir Crit Care Med; 2006 Jul; 174(1):84-93. PubMed ID: 16603606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric antimicrobial therapy of community-acquired pneumonia: clinical diagnosis versus procalcitonin levels.
    Cunha BA
    Scand J Infect Dis; 2009; 41(10):782-4. PubMed ID: 19681019
    [No Abstract]   [Full Text] [Related]  

  • 6. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T; Nanishi E; Kanno S; Nishio H; Kusuhara K; Hara T
    J Infect Chemother; 2014 Oct; 20(10):616-20. PubMed ID: 25027057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin in children admitted to hospital with community acquired pneumonia.
    Moulin F; Raymond J; Lorrot M; Marc E; Coste J; Iniguez JL; Kalifa G; Bohuon C; Gendrel D
    Arch Dis Child; 2001 Apr; 84(4):332-6. PubMed ID: 11259234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.
    Masiá M; Gutiérrez F; Shum C; Padilla S; Navarro JC; Flores E; Hernández I
    Chest; 2005 Oct; 128(4):2223-9. PubMed ID: 16236878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis.
    Hedlund J; Hansson LO
    Infection; 2000; 28(2):68-73. PubMed ID: 10782390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia.
    Self WH; Balk RA; Grijalva CG; Williams DJ; Zhu Y; Anderson EJ; Waterer GW; Courtney DM; Bramley AM; Trabue C; Fakhran S; Blaschke AJ; Jain S; Edwards KM; Wunderink RG
    Clin Infect Dis; 2017 Jul; 65(2):183-190. PubMed ID: 28407054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein, procalcitonin, clinical pulmonary infection score, and pneumonia severity scores in nursing home acquired pneumonia.
    Porfyridis I; Georgiadis G; Vogazianos P; Mitis G; Georgiou A
    Respir Care; 2014 Apr; 59(4):574-81. PubMed ID: 24106319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
    Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia. A pilot study.
    Piacentini E; Sánchez B; Arauzo V; Calbo E; Cuchi E; Nava JM
    J Crit Care; 2011 Apr; 26(2):201-5. PubMed ID: 20813489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia--a clinical observation in geriatric patients.
    Heppner HJ; Bertsch T; Alber B; Esslinger AS; Dragonas C; Bauer JM; Sieber CC
    Gerontology; 2010; 56(4):385-9. PubMed ID: 19940454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children.
    Toikka P; Irjala K; Juvén T; Virkki R; Mertsola J; Leinonen M; Ruuskanen O
    Pediatr Infect Dis J; 2000 Jul; 19(7):598-602. PubMed ID: 10917215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH; Wee JH; Choi SP; Oh SH
    Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
    Bafadhel M; Clark TW; Reid C; Medina MJ; Batham S; Barer MR; Nicholson KG; Brightling CE
    Chest; 2011 Jun; 139(6):1410-1418. PubMed ID: 21030489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of C-reactive protein and procalcitonin in differentiation of tuberculosis from bacterial community acquired pneumonia.
    Kang YA; Kwon SY; Yoon HI; Lee JH; Lee CT
    Korean J Intern Med; 2009 Dec; 24(4):337-42. PubMed ID: 19949732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of serum procalcitonin levels in pulmonary tuberculosis.
    Ugajin M; Miwa S; Shirai M; Ohba H; Eifuku T; Nakamura H; Suda T; Hayakawa H; Chida K
    Eur Respir J; 2011 Feb; 37(2):371-5. PubMed ID: 20530033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Procalcitonin in Differential Diagnosis of Pneumonia and Pulmonary Congestion Associated With End-Stage Renal Failure.
    Akçay Ş; Doğrul I; Sezer S; Haberal M
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):71-73. PubMed ID: 27805517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.